Multiple Component Pharmacokinetics after Oral Administration of Gnaphalium affine Extract in Rats
Planta Medica · 01.08.2023 · 89 (09) · 903-915
DOI: 10.1055/a-2021-2812 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.08.2023. Verfasst von Shiyi Han und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry Co., Ltd, China State Institute of Pharmaceutica…. Hauptthemen laut MEDLINE: Gnaphalium, Hyperuricemia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai, Data Center of Management Science, National Natural Science Foundation of China - Peking University.
Abstract (Originalsprache)
Gnaphalium affine is traditionally used to treat hyperuricemia and gout in China. Recently, the hypouricemic and renal protective effects of G. affine extract (GAD) have been deeply evaluated. However, little is known about the pharmacokinetics (PKs) of bioactive constituents in GAD. This study is aimed at investigating the individual and holistic pharmacokinetics of 10 bioactive components (including caffeic acid, caffeoylquinic acids, and flavonoids) in rats after single and multiple administrations of GAD. GAD is orally dosed to normal male rats at doses of 225, 450, or 900 mg/kg/day for 10 consecutive days and also orally administrated to uric acid nephropathy (UAN) rats at a dose of 900 mg/kg/day for 28 consecutive days. Integrated PKs of multiple components are calculated by area under the curve (AUC)-based weighting approach. All the components show a double-peak phenomenon in terms of their plasma concentration-time curves, suggesting that the components undergo enterohepatic circulation. The integrated AUC increases in a good dose-proportional manner with GAD dose. Compared with that in normal rats, the plasma exposure of caffeic acid and caffeoylquinic acids increases by 2.3- to 4.3-fold after 10-day chronic treatment of 900 mg/kg GAD in UAN rats. Modest drug accumulation is observed after 28-day chronic treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Lab. of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry Co., Ltd, China State Institute of Pharmaceutical Industry Co., Ltd, Shanghai, People's Republic of China.
Förderung
- Natural Science Foundation of Shanghai
- Data Center of Management Science, National Natural Science Foundation of China - Peking University
Zitieren
APA
Han, S., Liu, X., Chen, Y., Chen, J., Han, Q., & Fan, S. (2023). Multiple Component Pharmacokinetics after Oral Administration of Gnaphalium affine Extract in Rats. Planta Medica, 89(09), 903-915. https://doi.org/10.1055/a-2021-2812
Vancouver
Han S, Liu X, Chen Y, Chen J, Han Q, Fan S. Multiple Component Pharmacokinetics after Oral Administration of Gnaphalium affine Extract in Rats. Planta Medica. 2023;89(09):903-915. doi:10.1055/a-2021-2812
BibTeX
@article{Han2023,
author = {Han, Shiyi and Liu, Xizi and Chen, Ye and Chen, Junping and Han, Qinghua and Fan, Siyang},
title = {Multiple Component Pharmacokinetics after Oral Administration of Gnaphalium affine Extract in Rats},
journal = {Planta Medica},
year = {2023},
volume = {89},
number = {09},
pages = {903--915},
doi = {10.1055/a-2021-2812}
}
EUVIMED